Literature DB >> 25104845

Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.

Marian Muchada1, David Rodriguez-Luna1, Jorge Pagola1, Alan Flores1, Estela Sanjuan1, Pilar Meler1, Sandra Boned1, Jose Alvarez-Sabin1, Marc Ribo1, Carlos A Molina1, Marta Rubiera2.   

Abstract

BACKGROUND AND
PURPOSE: Although tissue-type plasminogen activator (tPA) efficacy depends on time, it is unknown whether its effect on recanalization is time dependent. Information about likelihood of successful recanalization as a function of time to treatment may improve patient selection for advanced reperfusion strategies. We aimed to identify the impact of time to treatment on tPA-induced recanalization in patients with acute ischemic stroke.
METHODS: Consecutive patients with intracranial acute occlusion treated with intravenous tPA underwent transcranial Doppler examination before and 1 hour after tPA administration. Patients were categorized according to occlusion localization in proximal and distal occlusion. Sequential analysis of recanalization according to time to treatment was performed for every 30-minute cutoff point.
RESULTS: Overall (n=508), 54.3% had proximal and 45.7% had distal occlusion. Median time to treatment was 171.4±61.9 minutes, and 5.9% were treated >270 minutes. Recanalization occurred in 36.1% of patients. There was no linear association between time to treatment and time to recanalization, but sequential analysis showed that patients treated >270 minutes had a lower recanalization rate. Lower National Institutes of Health Stroke Scale score on admission (odds ratio [OR], 0.305; 95% confidence interval [CI], 0.1-0.933) and time to treatment ≤270 minutes (OR, 0.995; 95% CI, 0.99-0.999) emerged as independent predictors of recanalization. In patients with proximal occlusion, 41.8% recanalized. Time to treatment >90 minutes was associated with lower recanalization rate. However, only younger age (OR, 0.975; 95% CI, 0.952-0.999) and lower baseline National Institutes of Health Stroke Scale score (OR, 0.921; 95% CI, 0.855-0.993) independently predicted recanalization. In distal occlusion patients, male sex was the only independent predictor of recanalization (OR, 0.416; 95% CI, 0.195-0.887). None recanalized >270 minutes.
CONCLUSIONS: The effect of tPA on recanalization may decrease over time. Treatment >270 minutes predicted lack of recanalization, especially in distal occlusions.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  stroke; time-to-treatment; tissue-type plasminogen activator

Mesh:

Substances:

Year:  2014        PMID: 25104845     DOI: 10.1161/STROKEAHA.114.006222

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Pavla Kadlecová; Anna Czlonkowska; Adam Kobayashi; Miroslav Brozman; Viktor Švigelj; Laszlo Csiba; Klara Fekete; Janika Kõrv; Vida Demarin; Aleksandras Vilionskis; Dalius Jatuzis; Yakup Krespi; Chrissoula Liantinioti; Sotirios Giannopoulos; Robert Mikulik
Journal:  J Neurol       Date:  2017-03-18       Impact factor: 4.849

2.  The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods.

Authors:  S Iris Deeds; Andrew Barreto; Jordan Elm; Colin P Derdeyn; Scott Berry; Pooja Khatri; Claudia Moy; Scott Janis; Joseph Broderick; James Grotta; Opeolu Adeoye
Journal:  Int J Stroke       Date:  2020-12-09       Impact factor: 5.266

3.  Outcomes and risk factors of perforating and non-perforating middle cerebral artery infarctions after intravenous thrombolysis.

Authors:  Hongyu Wei; Yiqing Wang; Yongjin Zhang; Shouyun Du; Jiahui Shen; Xiaojing Li; Hongjie Yan; Nizhuan Wang; Jianbing Zhu; Yi Wang; Zenglin Cai
Journal:  J Thromb Thrombolysis       Date:  2022-01-14       Impact factor: 2.300

4.  Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.

Authors:  Opeolu Adeoye; Heidi Sucharew; Jane Khoury; Achala Vagal; Pamela A Schmit; Irene Ewing; Steven R Levine; Stacie Demel; Bryan Eckerle; Brian Katz; Dawn Kleindorfer; Brian Stettler; Daniel Woo; Pooja Khatri; Joseph P Broderick; Arthur M Pancioli
Journal:  Stroke       Date:  2015-08-04       Impact factor: 7.914

5.  Towards reperfusion-centric preclinical stroke research: outside the box of "reperfusion injury".

Authors:  Chia Yi Kuan; Yu Yo Sun
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

6.  Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke.

Authors:  Georgios Tsivgoulis; Maher Saqqur; Vijay K Sharma; Alejandro Brunser; Jürgen Eggers; Robert Mikulik; Aristeidis H Katsanos; Theodore N Sergentanis; Konstantinos Vadikolias; Fabienne Perren; Marta Rubiera; Reza Bavarsad Shahripour; Huy Thang Nguyen; Patricia Martínez-Sánchez; Apostolos Safouris; Ioannis Heliopoulos; Ashfaq Shuaib; Carol Derksen; Konstantinos Voumvourakis; Theodora Psaltopoulou; Anne W Alexandrov; Andrei V Alexandrov
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

7.  Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke.

Authors:  Xu Tong; Yibin Cao; Wenzhi Wang; David Wang; Yongjun Wang; Yilong Wang
Journal:  Brain Behav       Date:  2020-09-05       Impact factor: 2.708

8.  Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up.

Authors:  Nam Hun Heo; Man Ryul Lee; Ki Hwa Yang; Ock Ran Hong; Ji Hyeon Shin; Bo Yeon Lee; Ji Young Lee; Jae Min Ahn; Hyuk Jin Oh; Jae Sang Oh
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.